Collegium Receives European Patent Allowance Covering Xtampza® ER by Seini Moimoi | Aug 1, 2016 | Portfolio News
Jazz Pharmaceuticals and Pfenex Enter into a Worldwide License and Option Agreement Related to Product Candidates in Early Development for Hematological Malignancies by Seini Moimoi | Jul 28, 2016 | Portfolio News
Aptinyx Initiates Dosing in Phase 1 Clinical Study of Lead NMDA-Receptor Modulator, NYX-2925 by Seini Moimoi | Jul 13, 2016 | Portfolio News
Zavante Lead Product Candidate, Zti-01 (Fosfomycin For Injection) Demonstrated In Vitro Activity Against Bacteria Resistant To Last Resort Antibiotic by Seini Moimoi | Jul 12, 2016 | Portfolio News
